News & Updates
Filter by Specialty:
Does fMRI neurofeedback improve symptoms, cognition in children with ADHD?
Nonpharmacological treatment with functional magnetic resonance imaging neurofeedback (fMRI-NF) of the right inferior frontal cortex (rIFC) does not seem effective in improving clinical symptoms or cognition in boys with attention deficit hyperactivity disorder (ADHD), reports a recent study.
Does fMRI neurofeedback improve symptoms, cognition in children with ADHD?
13 Dec 2022
Group CBT may help improve emotion regulation in adults with autism
Among adults with autism spectrum disorder (ASD), group-based cognitive behavioural therapy (CBT) appears to yield modest improvements in emotion regulation, a recent study has found.
Group CBT may help improve emotion regulation in adults with autism
04 Dec 2022
Mindfulness programme as effective as escitalopram in treating anxiety
Mindfulness-based stress reduction (MBSR) course is safe and as effective as first-line escitalopram for treatment of anxiety disorders, a randomized control trial has shown.
Mindfulness programme as effective as escitalopram in treating anxiety
04 Dec 2022
ADHD medication use carries no excess risk of cardiovascular diseases
Users of attention-deficit/hyperactivity disorder (ADHD) medications across age groups do not appear to be at increased risk of cardiovascular diseases (CVDs), although a modest risk increase of cardiac arrest or tachyarrhythmias could not be ruled out, according to the results of a meta-analysis.
ADHD medication use carries no excess risk of cardiovascular diseases
02 Dec 2022
SG, HK docs delay prescribing clozapine for treatment-resistant schizophrenia
Clinicians in Singapore and Hong Kong appear to delay the initiation of clozapine for treatment-resistant schizophrenia (TRS) despite familiarity with treatment guidelines, as reported in a study.